China Digest: C-Bridge invests in Nuance; YuanMing Capital backs Adlai Nortye

Shanghai-based healthcare PE fund C-Bridge Capital has led a $20 million Series B funding round into Nuance Biotech while YuanMing Capital has invested $50 million into Series B into Adlai Nortye.

C Bridge Capital leads $20m round in Nuance Biotech

Shanghai-based healthcare PE fund C-Bridge Capital has led a $20 million Series B funding round into Nuance Biotech, a China-based specialty pharma company.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter